SCHEMBL8909809

SCHEMBL8909809

CCOC(=O)C1=C(C)c2c(C)c3c(cc2=N1)-c1cc(F)ccc1N=3

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.37
GABRG2 P18507 4/20 0.36
GABRB3 P28472 4/20 0.36
GABRA5 P31644 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 3/20 0.36
GABRA2 P47869 2/20 0.36
GABRB2 P47870 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB1 P18505 1/20 0.36
CYP2C19 P33261 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA4 P48169 1/20 0.36
GABRE P78334 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8909498 0.91 TSHR (0.37) TSHRGABRG2GABRB3GABRA5MEN1
SCHEMBL8909720 0.88 DHODH (0.38) KMT2AALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL8909629 0.88 CA12 (0.39) GABRG2GABRB3GABRA5MEN1KMT2A
SCHEMBL9434374 0.87 SMAD3 (0.39) GABRG2GABRB3GABRA5ALDH1A1GABRA2
SCHEMBL8912086 0.86 CYP2C9 (0.39) TSHRMEN1KMT2AALDH1A1CYP1A2
SCHEMBL8911562 0.86 POLB (0.40) GABRG2GABRB3GABRA5ALDH1A1MAPT
SCHEMBL1388815 0.85 MAPT (0.44) TSHRGABRG2GABRB3GABRA5MEN1
SCHEMBL8365325 0.85 ABL1 (0.32)
SCHEMBL8910230 0.84 GABRA1 (0.38) TSHRGABRG2GABRB3GABRA5KMT2A
SCHEMBL8910758 0.80 DHODH (0.38) TSHRKMT2AALDH1A1SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US claimed
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US disclosed
EP-0651750-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1995-05-10 EP disclosed
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed